Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

NCT07206121 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast-conserving Surgery
Breast Cancer - Infiltrating Ductal Carcinoma
ER/PR+Her2neu
Grade I, II, III

Interventions

DEVICE: Radiofrequency ablation alone
DEVICE: Radiofrequency ablation Electrosurgical Device

Sponsor

Innoblative Designs, Inc.